Literature DB >> 26931183

HGVS Recommendations for the Description of Sequence Variants: 2016 Update.

Johan T den Dunnen1, Raymond Dalgleish2, Donna R Maglott3, Reece K Hart4, Marc S Greenblatt5, Jean McGowan-Jordan6, Anne-Francoise Roux7, Timothy Smith8, Stylianos E Antonarakis9, Peter E M Taschner10.   

Abstract

The consistent and unambiguous description of sequence variants is essential to report and exchange information on the analysis of a genome. In particular, DNA diagnostics critically depends on accurate and standardized description and sharing of the variants detected. The sequence variant nomenclature system proposed in 2000 by the Human Genome Variation Society has been widely adopted and has developed into an internationally accepted standard. The recommendations are currently commissioned through a Sequence Variant Description Working Group (SVD-WG) operating under the auspices of three international organizations: the Human Genome Variation Society (HGVS), the Human Variome Project (HVP), and the Human Genome Organization (HUGO). Requests for modifications and extensions go through the SVD-WG following a standard procedure including a community consultation step. Version numbers are assigned to the nomenclature system to allow users to specify the version used in their variant descriptions. Here, we present the current recommendations, HGVS version 15.11, and briefly summarize the changes that were made since the 2000 publication. Most focus has been on removing inconsistencies and tightening definitions allowing automatic data processing. An extensive version of the recommendations is available online, at http://www.HGVS.org/varnomen.
© 2016 WILEY PERIODICALS, INC.

Entities:  

Keywords:  database; mutation; nomenclature; sequence variation; standards

Mesh:

Year:  2016        PMID: 26931183     DOI: 10.1002/humu.22981

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  434 in total

1.  Human Immunoglobulin Heavy Gamma Chain Polymorphisms: Molecular Confirmation Of Proteomic Assessment.

Authors:  Magalie Dambrun; Célia Dechavanne; Alexandra Emmanuel; Florentin Aussenac; Marjorie Leduc; Chiara Giangrande; Joëlle Vinh; Jean-Michel Dugoujon; Marie-Paule Lefranc; François Guillonneau; Florence Migot-Nabias
Journal:  Mol Cell Proteomics       Date:  2017-03-06       Impact factor: 5.911

2.  An Extended SNOMED CT Concept Model for Observations in Molecular Genetics.

Authors:  James R Campbell; Geoffrey Talmon; Allison Cushman-Vokoun; Daniel Karlsson; W Scott Campbell
Journal:  AMIA Annu Symp Proc       Date:  2017-02-10

3.  Translational readthrough of GLA nonsense mutations suggests dominant-negative effects exerted by the interaction of wild-type and missense variants.

Authors:  Silvia Lombardi; Mattia Ferrarese; Saverio Marchi; Paolo Pinton; Mirko Pinotti; Francesco Bernardi; Alessio Branchini
Journal:  RNA Biol       Date:  2019-10-15       Impact factor: 4.652

Review 4.  Essential Characteristics of Pharmacogenomics Study Publications.

Authors:  Caroline F Thorn; Michelle Whirl-Carrillo; Houda Hachad; Julie A Johnson; Ellen M McDonagh; Mark J Ratain; Mary V Relling; Stuart A Scott; Russ B Altman; Teri E Klein
Journal:  Clin Pharmacol Ther       Date:  2019-01       Impact factor: 6.875

5.  Calmodulin mutations and life-threatening cardiac arrhythmias: insights from the International Calmodulinopathy Registry.

Authors:  Lia Crotti; Carla Spazzolini; David J Tester; Alice Ghidoni; Alban-Elouen Baruteau; Britt-Maria Beckmann; Elijah R Behr; Jeffrey S Bennett; Connie R Bezzina; Zahurul A Bhuiyan; Alpay Celiker; Marina Cerrone; Federica Dagradi; Gaetano M De Ferrari; Susan P Etheridge; Meena Fatah; Pablo Garcia-Pavia; Saleh Al-Ghamdi; Robert M Hamilton; Zuhair N Al-Hassnan; Minoru Horie; Juan Jimenez-Jaimez; Ronald J Kanter; Juan P Kaski; Maria-Christina Kotta; Najim Lahrouchi; Naomasa Makita; Gabrielle Norrish; Hans H Odland; Seiko Ohno; John Papagiannis; Gianfranco Parati; Nicole Sekarski; Kristian Tveten; Matteo Vatta; Gregory Webster; Arthur A M Wilde; Julianne Wojciak; Alfred L George; Michael J Ackerman; Peter J Schwartz
Journal:  Eur Heart J       Date:  2019-09-14       Impact factor: 29.983

6.  Mutation spectrum of PAH gene in phenylketonuria patients in Northwest China: identification of twenty novel variants.

Authors:  Yousheng Yan; Chuan Zhang; Xiaohua Jin; Qinhua Zhang; Lei Zheng; Xuan Feng; Shengju Hao; Huafang Gao; Xu Ma
Journal:  Metab Brain Dis       Date:  2019-02-12       Impact factor: 3.584

7.  Quality Assessment of Reporting Performance for EGFR Molecular Diagnosis in Non-Small Cell Lung Cancer.

Authors:  Yanxi Han; Rui Zhang; Guigao Lin; Kuo Zhang; Jiehong Xie; Jinming Li
Journal:  Oncologist       Date:  2017-07-12

8.  Preconception Carrier Screening by Genome Sequencing: Results from the Clinical Laboratory.

Authors:  Sumit Punj; Yassmine Akkari; Jennifer Huang; Fei Yang; Allison Creason; Christine Pak; Amiee Potter; Michael O Dorschner; Deborah A Nickerson; Peggy D Robertson; Gail P Jarvik; Laura M Amendola; Jennifer Schleit; Dana Kostiner Simpson; Alan F Rope; Jacob Reiss; Tia Kauffman; Marian J Gilmore; Patricia Himes; Benjamin Wilfond; Katrina A B Goddard; C Sue Richards
Journal:  Am J Hum Genet       Date:  2018-05-10       Impact factor: 11.025

9.  Mild Stress Conditions during Laboratory Culture Promote the Proliferation of Mutations That Negatively Affect Sigma B Activity in Listeria monocytogenes.

Authors:  Duarte N Guerreiro; Jialun Wu; Charlotte Dessaux; Ana H Oliveira; Teresa Tiensuu; Diana Gudynaite; Catarina M Marinho; Aoife Boyd; Francisco García-Del Portillo; Jörgen Johansson; Conor P O'Byrne
Journal:  J Bacteriol       Date:  2020-04-09       Impact factor: 3.490

10.  Single-channel properties of skeletal muscle ryanodine receptor pore Δ4923FF4924 in two brothers with a lethal form of fetal akinesia.

Authors:  Le Xu; Frederike L Harms; Venkat R Chirasani; Daniel A Pasek; Fanny Kortüm; Peter Meinecke; Nikolay V Dokholyan; Kerstin Kutsche; Gerhard Meissner
Journal:  Cell Calcium       Date:  2020-02-17       Impact factor: 6.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.